U.S. Markets open in 6 hrs 17 mins

ARA MAY 28 DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against American Renal Associates Holdings, Inc. - ARA

NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of American Renal Associates Holdings, Inc. (ARA) from August 10, 2016 through March 27, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for American Renal investors under the federal securities laws.

If you wish to serve as lead plaintiff, you must move the Court no later than May 28, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go http://zhanginvestorlaw.com/join-action-form/?slug=american-renal-associates-holdings-inc&id=1811 or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. or Spencer Lee toll-free at 800-991-3756 or email info@zhanginvestorlaw.com, slee@zhanginvestorlaw.com for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) issues with American Renal's accounting process for revenue recognition, collections, and related matters would give rise to an SEC investigation into the same, and increased regulatory scrutiny by the SEC; (2) American Renal's financial statements for the fiscal years 2014, 2015, 2016 and 2017 contained in its Annual Reports for the years ended December 31, 2016 and 2017, and its condensed consolidated financial statements in quarterly reports from 2016 through 2018 were false and could not be relied upon; (3) American Renal had material weaknesses in its internal control over financial reporting; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class has not been certified. You may retain counsel of your choice. You may take no action at this time and be an absent class member. Your ability to obtain a recovery is not dependent upon being a lead plaintiff.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Contact:

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756

SOURCE: Zhang Investor Law PC



View source version on accesswire.com:
https://www.accesswire.com/546256/ARA-MAY-28-DEADLINEZhang-Investor-Law-Reminds-Investors-of-Deadline-in-Securities-Class-Action-Lawsuit-Against-American-Renal-Associates-Holdings-Inc--ARA



View source version on accesswire.com:
https://www.accesswire.com/546256/ARA-MAY-28-DEADLINEZhang-Investor-Law-Reminds-Investors-of-Deadline-in-Securities-Class-Action-Lawsuit-Against-American-Renal-Associates-Holdings-Inc--ARA